Results 21 to 30 of about 746,766 (243)

Evaluation of the Performance of Widal Slide Agglutination Test Compared to Blood Culture and Evaluation of Interferon Gamma Response in the Diagnosis of Typhoid Fever

open access: yesUMYU Journal of Microbiology Research, 2020
Typhoid fever remains a significant public health challenge in developing countries, including Nigeria. The Widal test, widely used for diagnosing typhoid fever due to its simplicity and quick turnaround time, has raised concerns regarding its ...
Mujahid, N. S.   +6 more
doaj   +1 more source

Interferon-gamma: A Review

open access: yesImmunobiology, 1989
Article de synthese sur l'interferon gamma: role physiologique et utilisation therapeutique ...
Ijzermans, Jan N.M., Marquet, Richard L.
openaire   +3 more sources

Interferon-γ Inhibits Ebola Virus Infection.

open access: yesPLoS Pathogens, 2015
Ebola virus outbreaks, such as the 2014 Makona epidemic in West Africa, are episodic and deadly. Filovirus antivirals are currently not clinically available.
Bethany A Rhein   +11 more
doaj   +1 more source

Bovine NK cells can produce gamma interferon in response to the secreted mycobacterial proteins ESAT-6 and MPP14 but not in response to MPB70 [PDF]

open access: yes, 2005
Bovine NK cells have recently been characterized and the present study describes the interaction between NK cells, antigen-presenting cells, and secreted mycobacteriall proteins.
Jungersen, Gregers   +15 more
core   +1 more source

Open‐Label Pilot Study of Interferon Gamma–1b in Patients With Non‐Infantile Osteopetrosis

open access: yesJBMR Plus, 2022
The only treatment currently available for patients with severe infantile osteopetrosis is hematopoietic cell transplantation (HCT). HCT‐related toxicity and mortality risks typically preclude its use in non‐infantile patients, and other therapies are ...
Andrew Nguyen   +8 more
doaj   +1 more source

Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals

open access: yesInterdisciplinary Perspectives on Infectious Diseases, 2016
Although interferon-gamma, interleukin-10, and adiponectin are key immunopathogenesis mediators of tuberculosis, their association with clinical manifestations of early stage disease is inconclusive.
Nathan Shaviya   +3 more
doaj   +1 more source

PERAN INTERFERON GAMMA PADA INFEKSI MYCOBACTERIUM TUBERCULOSIS

open access: yesJKS (Jurnal Kedokteran Syiah Kuala), 2018
Abstrak. Penyakit tuberkulosis masih tetap merupakan masalah kesehatan yang utama di dunia. Penyakit ini menyebabkan angka kesakitan yang tinggi pada jutaan penduduk dunia setiap tahunnya.
Nur Wahyuniati, M.Imun M.Imun
doaj   +1 more source

Study of T1 Tobacco Transplastomic Plants Containing Human Gamma Interferon Gene (hIFNg) [PDF]

open access: yesمجله بیوتکنولوژی کشاورزی, 2014
In the recent decades the progress in plant biotechnology, especially in the field of molecular farming, has made it possible to produce a wide range of recombinant protein using plants as a novel production system and bioreactor.
Mozhgan Soleimani Zadeh   +3 more
doaj   +1 more source

1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation [PDF]

open access: yes, 2005
peer reviewed1alpha,25-Dihydroxyvitamin D3 (1alpha,25(OH)2D3), the activated vitamin D3 hormone, is a key regulator of calcium homeostasis and thereby indispensable for bone metabolism.
Frahm, Thomas   +9 more
core   +1 more source

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Background Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results.
Laura E Baldassari   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy